Special Issue "Virus-Like Particle Vaccines"

Viruses. 2020 Aug 10;12(8):872. doi: 10.3390/v12080872.

Authors

Monique Vogel^{1

2}, Martin F Bachmann^{1

2

3}

Affiliations

¹ University Hospital for Rheumatology, Immunology, and Allergology, University of Bern, 3010 Bern, Switzerland.
² Department of BioMedical Research, University of Bern, 3010 Bern, Switzerland.
³ Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), The Jenner Institute, University of Oxford, Oxford OX3 7BN, UK.

Abstract

Virus-like particles (VLPs) have become a key tool for vaccine developers and manufacturers [...].

Publication types

Editorial

MeSH terms

Animals
Humans
Vaccines, Virus-Like Particle* / immunology
Vaccines, Virus-Like Particle* / therapeutic use
Viral Vaccines* / immunology
Viral Vaccines* / therapeutic use
Virus Diseases / prevention & control*
Virus Diseases / therapy

Substances

Vaccines, Virus-Like Particle
Viral Vaccines